Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Plasma-Cell Myeloma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Very early researchLooking for participantsNCT07249073
What this trial is testing

CAR19-BCMA Dual-target CAR-T in the Treatment of Relapsed / Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
Institute of Hematology & Blood Diseases Hospital, China 9
Testing effectiveness (Phase 2)Ended earlyNCT01096810
What this trial is testing

Study of TBL 12 Sea Cucumber Extract for Patients With Untreated Asymptomatic Myeloma

Who this might be right for
Multiple Myeloma
Jagannath, Sundar, M.D. 20
Not applicableLooking for participantsNCT06988020
What this trial is testing

"Pseudo-scanner" MRI Sequences for the Detection of Bone Lesions in Multiple Myeloma

Who this might be right for
Multiple Myeloma Bone Disease
Cliniques universitaires Saint-Luc- Université Catholique de Louvain 45
Testing effectiveness (Phase 2)Study completedNCT04028115
What this trial is testing

Bone Healing During Ninlaro Exposure

Who this might be right for
Multiple Myeloma
Thomas Lund 30
Early research (Phase 1)Study completedNCT00477035
What this trial is testing

Post-transplant Autologous Cytokine-induced Killer (CIK) Cells for Treatment of High Risk Hematologic Malignancies

Who this might be right for
LeukemiaMultiple Myeloma
Sally Arai 22
Early research (Phase 1)Study completedNCT04121260
What this trial is testing

Subcutaneous Delivery of JNJ-54767414 in Chinese Participants With Multiple Myeloma

Who this might be right for
Multiple Myeloma
Janssen Research & Development, LLC 21
Not applicableStudy completedNCT04840680
What this trial is testing

Real-World Use of Ixazomib Citrate in People With Multiple Myeloma (MM)

Who this might be right for
Multiple Myeloma
Takeda 191
Not applicableLooking for participantsNCT05312255
What this trial is testing

Non-chemotherapeutic Interventions for the Improvement of Quality of Life and Immune Function in Patients With Multiple Myeloma

Who this might be right for
Plasma Cell MyelomaRecurrent Plasma Cell MyelomaRefractory Plasma Cell Myeloma+1 more
Roswell Park Cancer Institute 175
Testing effectiveness (Phase 2)Looking for participantsNCT04991103
What this trial is testing

Minimal Residual Disease Response-adapted Deferral of Transplant in Dysproteinemia (MILESTONE)

Who this might be right for
Multiple MyelomaAmyloidosis
University of Alabama at Birmingham 40
Not applicableNo Longer AvailableNCT00423826
What this trial is testing

Umbilical Cord Blood Stem Cell Transplant in Treating Patients With Hematologic Cancer or Other Disease

Who this might be right for
LeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+3 more
Barbara Ann Karmanos Cancer Institute
Testing effectiveness (Phase 2)Study completedNCT01502085
What this trial is testing

Vorinostat,Lenalinomide and Dexamethasone in Multiple Myeloma Refractory to Previous Lenalinomide Containing Regimens

Who this might be right for
Multiple Myeloma
Hackensack Meridian Health 25
Large-scale testing (Phase 3)Study completedNCT00416208
What this trial is testing

Consolidation Therapy With Bortezomib in Elderly Patients With Multiple Myeloma

Who this might be right for
Multiple Myeloma
Janssen-Cilag G.m.b.H 154
Testing effectiveness (Phase 2)Ended earlyNCT04205240
What this trial is testing

Reduce Intensity Conditioning Donor Stem Cell Transplant for the Treatment of Relapsed Multiple Myeloma

Who this might be right for
Recurrent Plasma Cell Myeloma
Srinivas Devarakonda 1
Early research (Phase 1)Study completedNCT00457782
What this trial is testing

A Phase I Safety, PK and PD Study of KW-2478 in Patients With Multiple Myeloma, Chronic Lymphocytic Leukaemia or B-cell Non-Hodgkin's Lymphoma

Who this might be right for
Multiple MyelomaChronic Lymphocytic LeukaemiaB-cell Non-Hodgkin's Lymphoma
Kyowa Kirin Co., Ltd. 27
Testing effectiveness (Phase 2)Looking for participantsNCT03314974
What this trial is testing

Myeloablative Allo HSCT With Related or Unrelated Donor for Heme Disorders

Who this might be right for
Acute LeukemiaAcute Myeloid LeukemiaAcute Lymphoblastic Leukemia+25 more
Masonic Cancer Center, University of Minnesota 300
Not applicableStudy completedNCT07614243
What this trial is testing

Long Non-coding RNA (lncRNA) ZFAS1-Mediated Mechanism of Roasted Nux Vomica in Intervening Bortezomib-Induced Peripheral Neuropathy

Who this might be right for
Multiple MyelomaChemotherapy-Induced Peripheral Neuropathy
The First Affiliated Hospital of Zhejiang Chinese Medical University 22
Testing effectiveness (Phase 2)Study completedNCT02639559
What this trial is testing

Safety and Efficacy of BL-8040 for the Mobilization of Donor Hematopoietic Stem Cells and Allogeneic Transplantation in Patients With Advanced Hematological Malignancies

Who this might be right for
Acute Myelogenous LeukemiaAcute Lymphoblastic LeukemiaChronic Myelogenous Leukemia+8 more
Washington University School of Medicine 50
Not applicableLooking for participantsNCT05160584
What this trial is testing

Real-Life Current Standards of Care in Participants With Relapsed and/or Refractory Multiple Myeloma

Who this might be right for
Relapsed/Refractory Multiple Myeloma
Janssen Pharmaceutica N.V., Belgium 300
Early research (Phase 1)Study completedNCT00689507
What this trial is testing

Safety Study of LY2127399 in Combination With Bortezomib

Who this might be right for
Multiple Myeloma
Applied Molecular Evolution 48
Testing effectiveness (Phase 2)Ended earlyNCT01965834
What this trial is testing

Phase II Study to Evaluate Fenofibrate Therapy in Patients With Smoldering or Symptomatic Multiple Myeloma

Who this might be right for
Multiple Myeloma
University of Miami 6
Next Page